<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; SLTM</title>
	<atom:link href="http://www.stockbloghub.com/tag/sltm/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(SLTM) Solta Medical Reports LipoSonix Approval</title>
		<link>http://www.stockbloghub.com/2011/10/27/sltm-solta-medical-reports-liposonix-approval/86028</link>
		<comments>http://www.stockbloghub.com/2011/10/27/sltm-solta-medical-reports-liposonix-approval/86028#comments</comments>
		<pubDate>Thu, 27 Oct 2011 17:26:41 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[AGN]]></category>
		<category><![CDATA[Allergan Inc.]]></category>
		<category><![CDATA[Cutera Inc]]></category>
		<category><![CDATA[CUTR]]></category>
		<category><![CDATA[ELOS]]></category>
		<category><![CDATA[Medicis Pharmaceutical Corporation]]></category>
		<category><![CDATA[MRX]]></category>
		<category><![CDATA[Palomar Medical Technologies Inc]]></category>
		<category><![CDATA[PMTI]]></category>
		<category><![CDATA[SLTM]]></category>
		<category><![CDATA[Solta Medical Inc]]></category>
		<category><![CDATA[Syneron Medical Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86028</guid>
		<description><![CDATA[Aesthetic laser treatments provider Solta Medical (SLTM) reported that Medicis Technologies Corporation, a unit of specialty pharmaceutical company Medicis Pharmaceutical Corporation (MRX), has won the U.S. approval for the second-generation LIPOSONIX system for non-invasive waist circumference reduction. Solta announced, in September 2011, the acquisition of Medicis Technologies Corporation in a deal worth $35 million. The acquisition, which is expected to be completed in fourth-quarter 2011, provides Solta with Medicis’ LIPOSONIX system which uses advanced non-invasive ultrasound energy to reduce abdominal fat. Under the agreement, Solta will pay $15 million to Medicis upon the completion of the deal. It will also pay up to $20 million contingent upon the attainment of near-term regulatory milestones in the U.S. Moreover, Solta would make additional future payments subject to the achievement of certain commercial ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/27/sltm-solta-medical-reports-liposonix-approval/86028/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MRX) Medicis Pharmaceutical Sells LipoSonix Business</title>
		<link>http://www.stockbloghub.com/2011/09/20/mrx-medicis-pharmaceutical-sells-liposonix-business/83304</link>
		<comments>http://www.stockbloghub.com/2011/09/20/mrx-medicis-pharmaceutical-sells-liposonix-business/83304#comments</comments>
		<pubDate>Tue, 20 Sep 2011 20:26:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medicis Pharmaceutical Corporation]]></category>
		<category><![CDATA[MRX]]></category>
		<category><![CDATA[SLTM]]></category>
		<category><![CDATA[Solta Medical Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83304</guid>
		<description><![CDATA[Medicis Pharmaceutical Corp. (MRX) recently announced to have entered into a ‘Stock Purchase Agreement’ with Solta Medical, Inc. (SLTM), under which the latter will acquire all the outstanding shares of Medicis Technologies Corporation (formerly LipoSonix, Inc.), a subsidiary of Medicis Pharma. The deal is expected to close in the fourth quarter of 2011. According to the agreement, Solta will make a payment of $15 million to Medicis Pharma following the closure of the deal. Additionally, Solta will pay up to $20 million to Medicis Pharma on the achievement of certain regulatory milestones. Medicis Pharma is also entitled to receive payments based on the future performance of the LipoSonix technologies. Solta&#8217;s obligation to make these additional future payments expires after about 7 years. We note that the LipoSonix system is currently ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/20/mrx-medicis-pharmaceutical-sells-liposonix-business/83304/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLTM) Solta Medical Buying Medicis Unit</title>
		<link>http://www.stockbloghub.com/2011/09/20/sltm-solta-medical-buying-medicis-unit/83359</link>
		<comments>http://www.stockbloghub.com/2011/09/20/sltm-solta-medical-buying-medicis-unit/83359#comments</comments>
		<pubDate>Tue, 20 Sep 2011 20:05:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[AGN]]></category>
		<category><![CDATA[Allergan Inc.]]></category>
		<category><![CDATA[Cutera Inc]]></category>
		<category><![CDATA[CUTR]]></category>
		<category><![CDATA[ELOS]]></category>
		<category><![CDATA[Medicis Pharmaceutical Corporation]]></category>
		<category><![CDATA[MRX]]></category>
		<category><![CDATA[Palomar Medical Technologies Inc]]></category>
		<category><![CDATA[PMTI]]></category>
		<category><![CDATA[SLTM]]></category>
		<category><![CDATA[Solta Medical Inc]]></category>
		<category><![CDATA[Syneron Medical Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83359</guid>
		<description><![CDATA[Aesthetic laser treatments provider Solta Medical (SLTM) has agreed to acquire Medicis Technologies Corporation, a unit of specialty pharmaceutical company Medicis Pharmaceutical Corporation (MRX), in a deal worth roughly $35 million. Under the agreement, Soltawill pay $15 million to Medicis upon the completion of the deal. It will also pay up to $20 million contingent upon the attainment of near-term regulatory milestones in the U.S. Moreover, Solta would make additional future payments subject to the achievement of certain commercial milestones. The acquisition, which is subject to customary closing conditions including antitrust clearance, is expected to close in fourth-quarter 2011. Solta plans to finance the transaction through its existing cash and credit facilities. The acquisition provides Solta with Medicis’ LIPOSONIX system, which uses advanced non-invasive ultrasound energy to reduce abdominal fat. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/20/sltm-solta-medical-buying-medicis-unit/83359/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLTM) Solta Medical&#8217;s Laser Device Approved by The FDA</title>
		<link>http://www.stockbloghub.com/2009/10/15/sltm-solta-medicals-laser-device-approved-by-the-fda/17788</link>
		<comments>http://www.stockbloghub.com/2009/10/15/sltm-solta-medicals-laser-device-approved-by-the-fda/17788#comments</comments>
		<pubDate>Thu, 15 Oct 2009 21:48:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[AGN]]></category>
		<category><![CDATA[Allergan Inc.]]></category>
		<category><![CDATA[Candela Corporation]]></category>
		<category><![CDATA[CLZR]]></category>
		<category><![CDATA[SLTM]]></category>
		<category><![CDATA[Solta Medical Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17788</guid>
		<description><![CDATA[After the closing bell on Wednesday, Solta Medical Inc. (SLTM) announced that the U.S. Food and Drug Administration (FDA) approved its device to clear pigmentation and other superficial skin conditions. The device, called the Fraxel re:store Dual Laser System, can be used both on the face and large body areas to clear pigmentation through a single treatment. Solta has already received approval for the device with 1550 nanometer (nm) wavelength for skin resurfacing and treatment of pigmented lesions and certain other dermatological conditions. The present FDA 510(k) clearance is for the Fraxel 1927 nm laser for dermatological procedures requiring the coagulation of soft tissue. Prior to its approval, laser skin resurfacing procedures were largely limited to the face. The approval of the new 1927 nm wavelength increases the areas of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/15/sltm-solta-medicals-laser-device-approved-by-the-fda/17788/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

